• Abstract

    Magnesium sulfate is a versatile therapeutic agent in maternal-fetal medicine, and its use during pregnancy has led to various clinical scenarios. This comprehensive review examines the multifaceted role of magnesium sulfate, addressing its benefits and potential risks. The mineral compound is limited for its efficacy in preventing and managing preeclampsia and eclampsia, providing neuroprotection for preterm infants, delaying preterm labor, and offering potential advantages in maternal and fetal health. However, its administration is complex, encompassing a range of maternal and fetal side effects and long-term implications. The decision to utilize magnesium sulfate during pregnancy necessitates a balanced assessment of its advantages and disadvantages, underscored by patient-centered care and shared decision-making. Future research and practice guidelines include pursuing personalized medicine, optimal dosing and administration, long-term follow-up, global health initiatives, and ethical considerations. The evolving landscape of research and emerging insights will continue to enhance maternal care and contribute to improved health outcomes for pregnant women and their infants.

  • References

    1. Aaserud, Morten, Simon Lewin, Simon Innvaer, Elizabeth J. Paulsen, Astrid T. Dahlgren, Mari Trommald, Lelia Duley, Merrick Zwarenstein, and Andrew D. Oxman. 2005. “Translating Research into Policy and Practice in Developing Countries: A Case Study of Magnesium Sulphate for Pre-Eclampsia.” BMC Health Services Research 5: 68. https://doi.org/10.1186/1472-6963-5-68.
    2. Alfahmi, Manal Z. 2022. “Patients’ Preference Approach to Overcome the Moral Implications of Family-Centred Decisions in Saudi Medical Settings.” BMC Medical Ethics 23 (December): 128. https://doi.org/10.1186/s12910-022-00868-8.
    3. Azria, E., V. Tsatsaris, F. Goffinet, G. Kayem, A. Mignon, and D. Cabrol. 2004. “[Magnesium sulfate in obstetrics: current data].” Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction 33 (6 Pt 1): 510–17. https://doi.org/10.1016/s0368-2315(04)96564-7.
    4. Bain, Emily, Tanya Bubner, Pat Ashwood, Emer Van Ryswyk, Lucy Simmonds, Sally Reid, Philippa Middleton, and Caroline A. Crowther. 2015. “Barriers and Enablers to Implementing Antenatal Magnesium Sulphate for Fetal Neuroprotection Guidelines: A Study Using the Theoretical Domains Framework.” BMC Pregnancy and Childbirth 15 (1): 176. https://doi.org/10.1186/s12884-015-0618-9.
    5. Bain, Emily S, Philippa F Middleton, and Caroline A Crowther. 2013. “Maternal Adverse Effects of Different Antenatal Magnesium Sulphate Regimens for Improving Maternal and Infant Outcomes: A Systematic Review.” BMC Pregnancy and Childbirth 13 (October): 195. https://doi.org/10.1186/1471-2393-13-195.
    6. Barbosa, Fabiano Timbó, Luciano Timbó Barbosa, Mário Jorge Jucá, and Rafael Martins da Cunha. 2010. “Applications of Magnesium Sulfate in Obstetrics and Anesthesia.” Revista Brasileira De Anestesiologia 60 (1): 104–10. https://doi.org/10.1016/s0034-7094(10)70013-1.
    7. Bell, Mandy J. 2010. “A Historical Overview of Preeclampsia-Eclampsia.” Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN / NAACOG 39 (5): 510–18. https://doi.org/10.1111/j.1552-6909.2010.01172.x.
    8. Bonanno, Clarissa, and Ronald J. Wapner. 2012. “Antenatal Corticosteroids in the Management of Preterm Birth: Are We Back Where We Started?” Obstetrics and Gynecology Clinics of North America 39 (1): 47–63. https://doi.org/10.1016/j.ogc.2011.12.006.
    9. Bozkurt, Ozlem, Zeynep Eras, Fuat Emre Canpolat, Serife Suna Oguz, Nurdan Uras, and Ugur Dilmen. 2016. “Antenatal Magnesium Sulfate and Neurodevelopmental Outcome of Preterm Infants Born to Preeclamptic Mothers.” The Journal of Maternal-Fetal & Neonatal Medicine: The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 29 (7): 1101–4. https://doi.org/10.3109/14767058.2015.1035641.
    10. Chawla, Nidhi, Hinal Shah, Kathleen Huynh, Alex Braun, Hanna Wollocko, and Nilank C. Shah. 2023. “The Role of Platelet-Activating Factor and Magnesium in Obstetrics and Gynecology: Is There Crosstalk between Pre-Eclampsia, Clinical Hypertension, and HELLP Syndrome?” Biomedicines 11 (5): 1343. https://doi.org/10.3390/biomedicines11051343.
    11. Chollat, Clément, Loïc Sentilhes, and Stéphane Marret. 2018. “Fetal Neuroprotection by Magnesium Sulfate: From Translational Research to Clinical Application.” Frontiers in Neurology 9 (April): 247. https://doi.org/10.3389/fneur.2018.00247.
    12. Cipolla, Marilyn J., and Richard P. Kraig. 2011. “Seizures in Women with Preeclampsia: Mechanisms and Management.” Fetal and Maternal Medicine Review 22 (02): 91–108. https://doi.org/10.1017/S0965539511000040.
    13. Commissioner, Office of the. 2021. “Classification of Products as Drugs and Devices and Additional Product Classification Issues.” FDA. May 12, 2021. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/classification-products-drugs-and-devices-and-additional-product-classification-issues.
    14. Conde-Agudelo, Agustín, and Roberto Romero. 2009. “ANTENATAL MAGNESIUM SULFATE FOR THE PREVENTION OF CEREBRAL PALSY IN PRETERM INFANTS <34 WEEKS’ GESTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS.” American Journal of Obstetrics and Gynecology 200 (6): 595–609. https://doi.org/10.1016/j.ajog.2009.04.005.
    15. Cunningham, John, Mariano Rodríguez, and Piergiorgio Messa. 2012. “Magnesium in Chronic Kidney Disease Stages 3 and 4 and in Dialysis Patients.” Clinical Kidney Journal 5 (Suppl 1): i39–51. https://doi.org/10.1093/ndtplus/sfr166.
    16. Dadelszen, Peter von, and Laura A. Magee. 2016. “Preventing Deaths Due to the Hypertensive Disorders of Pregnancy.” Best Practice & Research. Clinical Obstetrics & Gynaecology 36 (October): 83–102. https://doi.org/10.1016/j.bpobgyn.2016.05.005.
    17. DE JESUS, Lilia C., Beena G. SOOD, Seetha SHANKARAN, Mr. Douglas KENDRICK, Abhik DAS, Edward F. BELL, Barbara J. STOLL, et al. 2015. “Antenatal Magnesium Sulfate Exposure and Acute Cardiorespiratory Events in Preterm Infants.” American Journal of Obstetrics and Gynecology 212 (1): 94.e1-94.e7. https://doi.org/10.1016/j.ajog.2014.07.023.
    18. Deeksha, H S, Sandhya Pajai, and Srinidhi Cherukuri. n.d. “Study Based on the Alliance Between Serum Magnesium Levels and Preterm Labor: An Inclusive Review.” Cureus 15 (7): e42602. https://doi.org/10.7759/cureus.42602.
    19. Doll, Elizabeth, Jacob Wilkes, Lawrence J. Cook, E. Kent Korgenski, Roger G. Faix, Bradley A. Yoder, Rajendu Srivastava, et al. 2014. “Neonatal Magnesium Levels Correlate with Motor Outcomes in Premature Infants: A Long-Term Retrospective Cohort Study.” Frontiers in Pediatrics 2. https://www.frontiersin.org/articles/10.3389/fped.2014.00120.
    20. Eddy, KE, JP Vogel, RI Zahroh, and MA Bohren. 2022. “Factors Affecting Use of Magnesium Sulphate for Pre‐eclampsia or Eclampsia: A Qualitative Evidence Synthesis.” Bjog 129 (3): 379–91. https://doi.org/10.1111/1471-0528.16913.
    21. Einarson, Adrienne, Caroline Maltepe, Rada Boskovic, and Gideon Koren. 2007. “Treatment of Nausea and Vomiting in Pregnancy.” Canadian Family Physician 53 (12): 2109–11.
    22. Euser, Anna G., and Marilyn J. Cipolla. 2009. “Magnesium Sulfate Treatment for the Prevention of Eclampsia: A Brief Review.” Stroke; a Journal of Cerebral Circulation 40 (4): 1169–75. https://doi.org/10.1161/STROKEAHA.108.527788.
    23. Fanni, Daniela, C. Gerosa, V. M. Nurchi, M. Manchia, L. Saba, F. Coghe, G. Crisponi, et al. 2021. “The Role of Magnesium in Pregnancy and in Fetal Programming of Adult Diseases.” Biological Trace Element Research 199 (10): 3647–57. https://doi.org/10.1007/s12011-020-02513-0.
    24. Flenady, Vicki, Aleena M Wojcieszek, Dimitri NM Papatsonis, Owen M Stock, Linda Murray, Luke A Jardine, and Bruno Carbonne. 2014. “Calcium Channel Blockers for Inhibiting Preterm Labour and Birth.” The Cochrane Database of Systematic Reviews 2014 (6): CD002255. https://doi.org/10.1002/14651858.CD002255.pub2.
    25. Fogel, David B. 2018. “Factors Associated with Clinical Trials That Fail and Opportunities for Improving the Likelihood of Success: A Review.” Contemporary Clinical Trials Communications 11 (August): 156–64. https://doi.org/10.1016/j.conctc.2018.08.001.
    26. Galinsky, Robert, Justin M. Dean, Ingran Lingam, Nicola J. Robertson, Carina Mallard, Laura Bennet, and Alistair J. Gunn. 2020. “A Systematic Review of Magnesium Sulfate for Perinatal Neuroprotection: What Have We Learnt From the Past Decade?” Frontiers in Neurology 11. https://www.frontiersin.org/articles/10.3389/fneur.2020.00449.
    27. Gordon, Rebecca, Laura A. Magee, Beth Payne, Tabassum Firoz, Diane Sawchuck, Domena Tu, Marianne Vidler, Dane de Silva, and Peter von Dadelszen. 2014. “Magnesium Sulphate for the Management of Preeclampsia and Eclampsia in Low and Middle Income Countries: A Systematic Review of Tested Dosing Regimens.” Journal of Obstetrics and Gynaecology Canada: JOGC = Journal d’obstetrique et Gynecologie Du Canada: JOGC 36 (2): 154–63. https://doi.org/10.1016/S1701-2163(15)30662-9.
    28. Gragossian, Alin, Khalid Bashir, Beenish S. Bhutta, and Rotem Friede. 2023. “Hypomagnesemia.” In StatPearls. Treasure Island (FL): StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK500003/.
    29. Jain, Shubhi N, and Ashok M Mehendale. n.d. “A Review on Umbilical Cord Milking and Its Implications in Neonatal Health.” Cureus 14 (10): e30610. https://doi.org/10.7759/cureus.30610.
    30. Katageri, Geetanjali, Umesh Charantimath, Anjali Joshi, Marianne Vidler, Umesh Ramadurg, Sumedha Sharma, Sheshidhar Bannale, et al. 2018. “Availability and Use of Magnesium Sulphate at Health Care Facilities in Two Selected Districts of North Karnataka, India.” Reproductive Health 15 (Suppl 1): 91. https://doi.org/10.1186/s12978-018-0531-6.
    31. Kawagoe, Yasuyuki, Hiroshi Sameshima, Tsuyomu Ikenoue, Ichiro Yasuhi, and Tatsuhiko Kawarabayashi. 2011. “Magnesium Sulfate as a Second-Line Tocolytic Agent for Preterm Labor: A Randomized Controlled Trial in Kyushu Island.” Journal of Pregnancy 2011: 965060. https://doi.org/10.1155/2011/965060.
    32. Khayat, Samira, Hamed Fanaei, and Abdolhakim Ghanbarzehi. 2017. “Minerals in Pregnancy and Lactation: A Review Article.” Journal of Clinical and Diagnostic Research : JCDR 11 (9): QE01–5. https://doi.org/10.7860/JCDR/2017/28485.10626.
    33. Kusyanti, Tatik, Firman Fuad Wirakusumah, Fedri Ruluwedrata Rinawan, Abdul Muhith, Ayi Purbasari, Fitriana Mawardi, Indriana Widya Puspitasari, Afina Faza, and Alyxia Gita Stellata. 2022. “Technology-Based (Mhealth) and Standard/Traditional Maternal Care for Pregnant Woman: A Systematic Literature Review.” Healthcare 10 (7): 1287. https://doi.org/10.3390/healthcare10071287.
    34. Lee, Clare Yuen Zen, Pairote Chakranon, and Shaun Wen Huey Lee. 2019. “Comparative Efficacy and Safety of Neuroprotective Therapies for Neonates With Hypoxic Ischemic Encephalopathy: A Network Meta-Analysis.” Frontiers in Pharmacology 10 (October): 1221. https://doi.org/10.3389/fphar.2019.01221.
    35. Long, Q, OT Oladapo, S Leathersich, JP Vogel, G Carroli, P Lumbiganon, Z Qureshi, and AM Gülmezoglu. 2017. “Clinical Practice Patterns on the Use of Magnesium Sulphate for Treatment of Pre‐eclampsia and Eclampsia: A Multi‐country Survey.” Bjog 124 (12): 1883–90. https://doi.org/10.1111/1471-0528.14400.
    36. López Gómez, Lucía, Miguel A. Marín Gabriel, Begoña Encinas, Juan J. de la Cruz Troca, and Belén Rodríguez Marrodán. 2018. “Oxytocin Receptor Antagonist (Atosiban) in the Threat of Preterm Birth: Does It Have Any Effect on Breastfeeding in the Term Newborn?” Breastfeeding Medicine: The Official Journal of the Academy of Breastfeeding Medicine 13 (2): 123–28. https://doi.org/10.1089/bfm.2017.0206.
    37. Loudon, Jenifer A. Z., Kate M. Groom, and Philip R. Bennett. 2003. “Prostaglandin Inhibitors in Preterm Labour.” Best Practice & Research. Clinical Obstetrics & Gynaecology 17 (5): 731–44. https://doi.org/10.1016/s1521-6934(03)00047-6.
    38. Lu, J. F., and C. H. Nightingale. 2000. “Magnesium Sulfate in Eclampsia and Pre-Eclampsia: Pharmacokinetic Principles.” Clinical Pharmacokinetics 38 (4): 305–14. https://doi.org/10.2165/00003088-200038040-00002.
    39. “Magnesium Sulphate Mgso4: Topics by Science.Gov.” n.d. Accessed October 31, 2023. https://www.science.gov/topicpages/m/magnesium+sulphate+mgso4.
    40. Matsuda, Y., Y. Maeda, M. Ito, H. Sakamoto, N. Masaoka, M. Takada, and K. Sato. 1997. “Effect of Magnesium Sulfate Treatment on Neonatal Bone Abnormalities.” Gynecologic and Obstetric Investigation 44 (2): 82–88. https://doi.org/10.1159/000291492.
    41. Mayer, Christopher, and Irasema Apodaca-Ramos. 2023. “Tocolysis.” In StatPearls. Treasure Island (FL): StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK562212/.
    42. Miller, Emily M.S., Allie Sakowicz, Elise Leger, Elizabeth Lange, and Lynn M. Yee. 2021. “Association between Receipt of Intrapartum Magnesium Sulfate and Postpartum Hemorrhage.” AJP Reports 11 (1): e21–25. https://doi.org/10.1055/s-0040-1721671.
    43. Modanlou Juibari, Hamed, Hamid Reza Eftekharian, and Hamid Reza Arabion. 2016. “Intravenous Magnesium Sulfate to Deliberate Hypotension and Bleeding after Bimaxillary Orthognathic Surgery; A Randomized Double-Blind Controlled Trial.” Journal of Dentistry 17 (3 Suppl): 276–82.
    44. Moradi, Yousef, Rozhin Khateri, Ladan Haghighi, Shoaib Dehghani, Shiva Mansouri Hanis, Mehrdad Valipour, Zahra Najmi, Zahra Fathollahy, Meisam Allahmoradi, and Kamyar Mansori. 2020. “The Effect of Antenatal Magnesium Sulfate on Intraventricular Hemorrhage in Premature Infants: A Systematic Review and Meta-Analysis.” Obstetrics & Gynecology Science 63 (4): 395–406. https://doi.org/10.5468/ogs.19210.
    45. “Muscle Weakness: 12 Causes and More.” 2019. July 26, 2019. https://www.medicalnewstoday.com/articles/325876.
    46. Olofsson, P., B. Forsberg, K. Marsál, and N. O. Sjöberg. 1992. “Short-Term Effect of Magnesium Sulfate Infusion on Renal Function in Preeclamptic Women.” Journal of Perinatal Medicine 20 (5): 361–64. https://doi.org/10.1515/jpme.1992.20.5.361.
    47. Padda, Jaskamal, Khizer Khalid, Lanson B Colaco, Sandeep Padda, Nymisha L Boddeti, Armughan S Khan, Ayden Charlene Cooper, and Gutteridge Jean-Charles. n.d. “Efficacy of Magnesium Sulfate on Maternal Mortality in Eclampsia.” Cureus 13 (8): e17322. https://doi.org/10.7759/cureus.17322.
    48. Petla, Lakshmi Tanuja, Rosy Chikkala, K.S. Ratnakar, Vijayalakshmi Kodati, and V. Sritharan. 2013. “Biomarkers for the Management of Pre-Eclampsia in Pregnant Women.” The Indian Journal of Medical Research 138 (1): 60–67.
    49. Popkin, Barry M., Kristen E. D’Anci, and Irwin H. Rosenberg. 2010. “Water, Hydration and Health.” Nutrition Reviews 68 (8): 439–58. https://doi.org/10.1111/j.1753-4887.2010.00304.x.
    50. PubChem. n.d. “Magnesium Sulfate.” Accessed October 31, 2023. https://pubchem.ncbi.nlm.nih.gov/compound/24083.
    51. Rouse, Dwight J., Deborah G. Hirtz, Elizabeth Thom, Michael W. Varner, Catherine Y. Spong, Brian M. Mercer, Jay D. Iams, et al. 2008. “A Randomized, Controlled Trial of Magnesium Sulfate for the Prevention of Cerebral Palsy.” The New England Journal of Medicine 359 (9): 895–905. https://doi.org/10.1056/NEJMoa0801187.
    52. Satyanarayana Rao, K H. 2008. “Informed Consent: An Ethical Obligation or Legal Compulsion?” Journal of Cutaneous and Aesthetic Surgery 1 (1): 33–35. https://doi.org/10.4103/0974-2077.41159.
    53. Sebastiani, Giorgia, Elisabet Navarro-Tapia, Laura Almeida-Toledano, Mariona Serra-Delgado, Anna Lucia Paltrinieri, Óscar García-Algar, and Vicente Andreu-Fernández. 2022. “Effects of Antioxidant Intake on Fetal Development and Maternal/Neonatal Health during Pregnancy.” Antioxidants 11 (4): 648. https://doi.org/10.3390/antiox11040648.
    54. “Severe Pre-Eclampsia/Eclampsia, Management (Green-Top Guideline No. 10A).” n.d. RCOG. Accessed October 31, 2023. https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/severe-pre-eclampsiaeclampsia-management-green-top-guideline-no-10a/.
    55. Shennan, Andrew, Natalie Suff, Bo Jacobsson, Jo Leigh Simpson, Jane Norman, William A. Grobman, Ana Bianchi, Stephen Mujanja, Catalina M. Valencia, and Ben W. Mol. 2021. “FIGO Good Practice Recommendations on Magnesium Sulfate Administration for Preterm Fetal Neuroprotection.” International Journal of Gynaecology and Obstetrics 155 (1): 31–33. https://doi.org/10.1002/ijgo.13856.
    56. Simon, Judit, Alastair Gray, Lelia Duley, and Magpie Trial Collaborative Group. 2006. “Cost-Effectiveness of Prophylactic Magnesium Sulphate for 9996 Women with Pre-Eclampsia from 33 Countries: Economic Evaluation of the Magpie Trial.” BJOG: An International Journal of Obstetrics and Gynaecology 113 (2): 144–51. https://doi.org/10.1111/j.1471-0528.2005.00785.x.
    57. Stevenson, David K., Ronald J. Wong, Nima Aghaeepour, Ivana Maric, Martin S. Angst, Kevin Contrepois, Gary L. Darmstadt, et al. 2021. “Towards Personalized Medicine in Maternal and Child Health: Integrating Biologic and Social Determinants.” Pediatric Research 89 (2): 252–58. https://doi.org/10.1038/s41390-020-0981-8.
    58. Tang, Jiaqi, Axin He, Na Li, Xueyi Chen, Xiuwen Zhou, Xiaorong Fan, Yanping Liu, et al. 2018. “Magnesium Sulfate-Mediated Vascular Relaxation and Calcium Channel Activity in Placental Vessels Different From Nonplacental Vessels.” Journal of the American Heart Association 7 (14): e009896. https://doi.org/10.1161/JAHA.118.009896.
    59. Wedig, K. E., J. Kogan, E. K. Schorry, and J. A. Whitsett. 2006. “Skeletal Demineralization and Fractures Caused by Fetal Magnesium Toxicity.” Journal of Perinatology: Official Journal of the California Perinatal Association 26 (6): 371–74. https://doi.org/10.1038/sj.jp.7211508.
    60. “WHO Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia.” n.d. Accessed October 31, 2023. https://www.who.int/publications-detail-redirect/9789241548335.
    61. Wilson, Amie, Victoria A. Hodgetts-Morton, Ella J. Marson, Alexandra D. Markland, Eva Larkai, Argyro Papadopoulou, Arri Coomarasamy, et al. 2022. “Tocolytics for Delaying Preterm Birth: A Network Meta-Analysis (0924).” The Cochrane Database of Systematic Reviews 8 (8): CD014978. https://doi.org/10.1002/14651858.CD014978.pub2.
    62. Younger, Joshua D., Elena Reitman, and George Gallos. 2017. “Tocolysis: Present and Future Treatment Options.” Seminars in Perinatology 41 (8): 493–504. https://doi.org/10.1053/j.semperi.2017.08.008.
    63. Zarean, Elaheh, and Amal Tarjan. 2017. “Effect of Magnesium Supplement on Pregnancy Outcomes: A Randomized Control Trial.” Advanced Biomedical Research 6 (August): 109. https://doi.org/10.4103/2277-9175.213879.
    64. Zeng, Xianling, Yan Xue, Quan Tian, Rong Sun, and Ruifang An. 2016. “Effects and Safety of Magnesium Sulfate on Neuroprotection.” Medicine 95 (1): e2451. https://doi.org/10.1097/MD.0000000000002451.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2023 Multidisciplinary Reviews

How to cite

Wanjari, M., Late, S., Umate, S., Choudhary, M., Munjewar, P., Lohakare, T., Sharma, R., Singh, S., Gawai, J., Taksande, V., Mendhe, D., & Meghe, A. (2023). Role of magnesium sulfate in pregnancy: A comprehensive review of benefits and risks. Multidisciplinary Reviews, (| Accepted Articles). Retrieved from https://malque.pub/ojs/index.php/mr/article/view/1761
  • Article viewed - 141